Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06264232 · ClinicalTrials.gov registry record · NA
AT ELANA 841P Posterior Chamber Intraocular Lens for Correction of Aphakia Following Cataract Removal
A NA study, sponsored by Carl Zeiss Meditec.
- Completed
- Registry status
- NA
- Development phase
- 284
- Enrollment target
NCT06264232 is a NA study that has completed, run by Carl Zeiss Meditec. The registered enrollment target is 284 participants.
The verdict
NCT06264232, a NA study, has completed, sponsored by Carl Zeiss Meditec.
- COMPLETED
- Registry status
- NA
- Development phase
- 284 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to demonstrate the safety and effectiveness of the full visual range AT ELANA 841P IOL when used to treat adult patients having cataract surgery. Subjects will be randomly selected to receive a pair of IOLs, either the AT ELANA 841P or CT LUCIA 621P lens design. All patients will undergo surgery in both eyes, and they will receive follow up care for up to 6-months. During this time, all patients will undergo thorough eye exams at every study visit and complete questionnaires about their quality of vision post-surgery.
Interventions
- DEVICE Cataract Surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 284 participants |
| Start Date | 2024-07-12 |
| Est. Completion | 2025-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06264232
The ClinicalTrials.gov registry entry for NCT06264232 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 284 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carl Zeiss Meditec, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cataract Surgery is the first listed.
NCT06264232 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06264232 about?
NCT06264232 is a clinical study titled "AT ELANA 841P Posterior Chamber Intraocular Lens for Correction of Aphakia Following Cataract Removal". The goal of this clinical trial is to demonstrate the safety and effectiveness of the full visual range AT ELANA 841P IOL when used to treat adult patients having cataract surgery. Subjects will be randomly selected to receive a pair of IOLs, either the AT ELANA 841P or CT LUCIA 621P lens design. Al...
What is the current status of trial NCT06264232?
This trial is currently completed. It is a NA study. The enrollment target is 284 participants. The study started on 2024-07-12. Estimated completion is 2025-12-01.
What interventions are being tested in trial NCT06264232?
The interventions under investigation include: Cataract Surgery (DEVICE).
Who is sponsoring clinical trial NCT06264232?
This trial is sponsored by Carl Zeiss Meditec, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.